SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-18-046879
Filing Date
2018-07-25
Accepted
2018-07-25 12:51:20
Documents
8
Effectiveness Date
2018-07-25

Document Format Files

Seq Description Document Type Size
1 S-8 a18-17513_4s8.htm S-8 115022
2 EX-5.1 a18-17513_4ex5d1.htm EX-5.1 25143
3 EX-23.2 a18-17513_4ex23d2.htm EX-23.2 4641
4 EX-23.3 a18-17513_4ex23d3.htm EX-23.3 2702
5 EX-23.4 a18-17513_4ex23d4.htm EX-23.4 4629
6 EX-99.2 a18-17513_4ex99d2.htm EX-99.2 74090
7 EX-99.3 a18-17513_4ex99d3.htm EX-99.3 61759
8 GRAPHIC g175134kii001.jpg GRAPHIC 2064
  Complete submission text file 0001104659-18-046879.txt   292071
Mailing Address 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406
Business Address 56 FITZWILLIAM SQUARE DUBLIN L2 2 (610) 816-6640
Nabriva Therapeutics plc (Filer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-226330 | Film No.: 18968293
SIC: 2834 Pharmaceutical Preparations